Register  /  Login      
  1. Home
  2. Pharma Horizon
  3. Pharma Horizon News from Companies

Pharma Horizon News from Companies

01/09/2017
Merrimack will focus on developing innovative and promising anti-cancer agents through clinical proof-of-concept (PoC)
01/09/2017
Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease
01/09/2017
Zymtronix to discuss revolutionary technology at Cambridge Health Institute’s 16th Annual Peptalk: The Protein Science Week
01/09/2017
Prokarium and Probiomed in UK-Mexico collaboration to scale-up manufacture of thermostable vaccines with a focus on diarrhoea
01/09/2017
Quotient Bioresearch is Now Pharmaron
01/09/2017
Noxxon pharma licenses and assigns preclinical spiegelmer programs to aptarion
01/05/2017
Prima BioMed announces new product candidate IMP761 – a LAG-3 agonist antibody
01/05/2017
Business alliance in pharmaceutical additives between SPI Pharma and Asahi Kasei Chemicals
01/04/2017
Growing Chemistry CRO YProtech adds High Potency Capabilities
01/04/2017
Almac Group announces significant expansion in pharmaceutical development capacity
01/03/2017
VolitionRx Limited’s novel cancer diagnostic test achieves CE marking as it prepares for launch across Europe
01/03/2017
ViiV Healthcare announces start of phase III study evaluating long-acting cabotegravir for HIV prevention
01/03/2017
Kubota Pharmaceutical Holdings Signs Letter of Intent to Form a Joint Venture with SBI Holdings
12/30/2016
Chinese Biotech Investor VIROAD takes over GILUPI
12/21/2016
Sterling and TPI strike codeine agreement
12/20/2016
CE – Marking certification for two new products: Gastrap® and FiberSlim™

  • Recent Posts